C Cheng Holdings Limited - 1486.HK

1486.HK Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
1486.HK	0	0	0	-27.1	-27.1	-28.6	-64.6	-78.8	-73.7	-67.3
S&P 500	0.8	1.7	2.8	4.2	9.6	25.7	38.2	83.5	195.5	34422.1

Compare 1486.HK with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	1486.HK
name	C Cheng Holdings Limited
price	0.35
changes percentage	0
change	0
day low	0.35
day high	0.35
year high	0.59
year low	0.31
market cap	100891350
price avg 50	0.3737
price avg 200	0.435175
exchange	HKSE
volume	22000
avg volume	4967
open	0.35
previous close	0.35
eps	-0.11
pe	-3.18
earnings announcement	2025-03-27T12:00:00.000+0000
shares outstanding	288261000
timestamp	2025-01-15 06:52:15

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 30.3%

Overall Quarterly Financial Health: 50.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	454250000	682667000	-33.46
gross profit	58542000	108427000	-46.01
gross profit ratio	0.13	0.16	-18.86
research and development expenses	0	0	NaN
operating expenses	92026000	106904000	-13.92
interest income	633000	1306000	-51.53
interest expense	6561000	4914000	33.52
ebitda	2443999	18592000	-86.85
ebitdaratio	0.01	0.07	-92.23
operating income	-33484000	2573000	-1401.36
operating income ratio	-0.07	0.0	-2055.74
net income	-21240000	-11136000	-90.73
net income ratio	-0.05	-0.02	-186.64
eps	-0.07	-0.04	-90.93

Overall Score of Annual Income Statement

0.29 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 454 million in 2023 from 683 million in 2022 representing a change of -33.46%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 59 million in 2023 from 108 million in 2022 representing a change of -46.01%. This indicates a sales profitability decline, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 92 million in 2023 from 107 million in 2022 representing a change of -13.92%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Operating Income: Operating income decreased to -33 million in 2023 from 3 million in 2022 representing a change of -1401.36%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Earnings per Share (EPS): EPS increased to -0.07 in 2023 from -0.07 in 2022 representing a change of -90.93%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 2 million in 2023 from 19 million in 2022 representing a change of -86.85%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Net Income: Net income increased to -21 million in 2023 from -11 million in 2022 representing a change of -90.73%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
revenue	103192500	103192500	0.0
gross profit	14929500	14929500	0.0
gross profit ratio	0.14	0.14	0.0
research and development expenses	0	0	NaN
operating expenses	20077000	20077000	0.0
interest income	0	0	NaN
interest expense	4032000	0	NaN
ebitda	946000	946000	0.0
ebitdaratio	0.01	0.01	0.0
operating income	-5147500	-5147500	0.0
operating income ratio	-0.05	-0.05	0.0
net income	-6097500	-6097500	0.0
net income ratio	-0.06	-0.06	0.0
eps	-0.02	-0.02	0.0

Overall Score of Quarterly Income Statement

0.5 out of 1

Detailed Analysis

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	683198000	834203000	-18.10
total liabilities	265203000	328581000	-19.29
total equity	417995000	505622000	-17.33
cash and cash equivalents	90101000	160869000	-43.99
short term investments	7005000	11974000	-41.50
long term investments	92856000	-7988000	1262.44
total current assets	526491000	712305000	-26.09
total non current assets	156707000	121898000	28.56
total current liabilities	250282000	290424000	-13.82
total non current liabilities	14921000	38157000	-60.90
common stock	2883000	2883000	0.00
retained earnings	153448000	168482000	-8.92
total debt	118843000	147267000	-19.30

Overall Score of Annual Balance Sheet

0.33 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 683 million in 2023 from 834 million in 2022 representing a change of -18.1%. Suggesting a decrease in asset holdings.

  Total Equity: Total Equity decreased to 418 million in 2023 from 506 million in 2022 representing a change of -17.33%. This indicates a decrease in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 90 million in 2023 from 161 million in 2022 representing a change of -43.99%. This indicates a decrease in available liquid assets.

  Short Term Investments: Short Term Investments decreased to 7 million in 2023 from 12 million in 2022 representing a change of -41.5%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 526 million in 2023 from 712 million in 2022 representing a change of -26.09%. This indicates a worsen liquidity position.

  Retained Earnings: Retained Earnings decreased to 153 million in 2023 from 168 million in 2022 representing a change of -8.92%. This indicates an accumulated losses.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 265 million in 2023 from 329 million in 2022 representing a change of -19.29%. This indicates a decrease in overall liabilities.

  Total Current Liabilities: Total Current Liabilities decreased to 250 million in 2023 from 290 million in 2022 representing a change of -13.82%. This indicates a lower short-term debt burden.

  Total Debt: Total Debt decreased to 119 million in 2023 from 147 million in 2022 representing a change of -19.3%. This indicates a reduction in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
total assets	635181000	635181000	0.00
total liabilities	232501000	232501000	0.00
total equity	402680000	402680000	0.00
cash and cash equivalents	77933000	77933000	0.00
short term investments	8377000	8377000	0.00
long term investments	101548000	101548000	0.00
total current assets	479188000	479188000	0.00
total non current assets	155993000	155993000	0.00
total current liabilities	222835000	222835000	0.00
total non current liabilities	9666000	9666000	0.00
common stock	2883000	2883000	0.00
retained earnings	151846000	151846000	0.00
total debt	111354000	91472000	21.74

Overall Score of Quarterly Balance Sheet

0.0 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Debt: Total Debt increased to 111 million in 2024Q2 from 91 million in 2024Q1 representing a change of 21.74%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-114848000	-37259000	-208.24
operating cash flow	-15163000	148000	-10345.27
free cash flow	-19458000	-10737000	-81.22
capital expenditure	-4295000	-10885000	60.54
depreciation and amortization	32581000	44675000	-27.07
deferred income tax	0	0	NaN
stock based compensation	2073999	6264000	-66.89
accounts payables	0	8490000	-100.00
inventory	0	0	NaN
acquisitions net	-19142000	346000	-5632.37
investments in property plant and equipment	-4295000	-10885000	60.54
net cash used for investing activites	-87325000	-7084000	-1132.71
debt repayment	6024000	9695000	-37.86
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	-10783000	-21336000	49.46
cash at end of period	46021000	160869000	-71.39
accounts receivables	14437000	-46783000	130.86
cash at beginning of period	160869000	198128000	-18.81

Overall Score of Annual Cashflow Statement

0.29 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -115 million in 2023 from -37 million in 2022 representing a change of -208.24%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to -15 million in 2023 from 0 million in 2022 representing a change of -10345.27%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to -19 million in 2023 from -11 million in 2022 representing a change of -81.22%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -4 million in 2023 from -11 million in 2022 representing a change of 60.54%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Receivables: Accounts Receivables increased to 14 in 2023 from -47 million in 2022 representing a change of 130.86%. This suggests that the company is less capable of collecting payments from its customers.

• 📈 Positive Indicators

  Stock-Based Compensation: Stock-Based Compensation decreased to 2 million in 2023 from 6 million in 2022 representing a change of -66.89%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2023 from 8 million in 2022 representing a change of -100.0%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
operating cash flow	3094000	3094000	0.00
free cash flow	2574000	2574000	0.00
capital expenditure	-520000	-520000	0.00
depreciation and amortization	12187000	6093500	100.00
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	14729000	14729000	0.00
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	-520000	-520000	0.00
net cash used for investing activites	-4734000	-4734000	0.00
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	-3693000	-3693000	0.00
net change in cash	0	-6084000	100.00
cash at end of period	77933000	-6084000	1380.95
cash at beginning of period	46021000	0	NaN

Overall Score of Quarterly Cashflow Statement

1.0 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 0 million in 2024Q2 from -6 million in 2024Q1 representing a change of 100.0%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	1.58	2.37	-33.46
net income per share	-0.07	-0.04	-90.73
operating cash flow per share	-0.05	0.0	-10345.27
free cash flow per share	-0.07	-0.04	-81.22
cash per share	0.34	0.6	-43.82
book value per share	1.45	1.75	-17.33
tangible book value per share	1.43	1.67	-13.87
shareholders equity per share	1.44	1.52	-5.11
interest debt per share	0.44	0.53	-17.60
market cap	141247782.2	221960800.6	-36.36
enterprise value	169989782.2	208358800.6	-18.41
pe ratio	-6.65	-19.93	66.64
price to sales ratio	0.31	0.33	-4.36
pocfratio	-9.32	1499.74	-100.62
pfcf ratio	-7.26	-20.67	64.89
pb ratio	0.34	0.51	-32.93
ptb ratio	0.34	0.51	-32.93
ev to sales	0.37	0.31	22.61
enterprise value over ebitda	69.55	11.21	520.63
ev to operating cash flow	-11.21	1407.83	-100.80
ev to free cash flow	-8.74	-19.41	54.98
earnings yield	-0.15	-0.05	-199.72
free cash flow yield	-0.14	-0.05	-184.78
debt to equity	0.29	0.34	-14.95
debt to assets	0.17	0.18	-1.46
net debt to ebitda	11.76	-0.73	1707.46
current ratio	2.1	2.45	-14.23
interest coverage	-5.1	0.52	-1074.68
income quality	0.44	-0.01	3068.47
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.2	0.18	11.56
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0.01	0.03	-78.52
capex to operating cash flow	-0.28	73.55	-100.39
capex to revenue	0.01	0.02	-40.70
capex to depreciation	0.13	0.24	-45.90
stock based compensation to revenue	0.0	0.01	-50.24
graham number	1.55	1.15	34.53
roic	-0.06	0.0	-1404.08
return on tangible assets	-0.03	-0.01	-127.26
graham net net	0.44	0.69	-37.04
working capital	276209000	421881000	-34.53
tangible asset value	413506000	480105000	-13.87
net current asset value	261288000	383724000	-31.91
invested capital	317112000	520169000	-39.04
average receivables	436897500	468596000	-6.76
average payables	22393500	12842500	74.37
average inventory	-5986999.5	-14588499.5	58.96
days sales outstanding	314.84	257.69	22.17
days payables outstanding	26.76	10.03	166.97
days of inventory on hand	0	-7.61	100.00
receivables turnover	1.16	1.42	-18.15
payables turnover	13.64	36.41	-62.54
inventory turnover	0	-47.96	100.00
roe	-0.05	-0.03	-101.01
capex per share	0.01	0.04	-60.54

• Negative

  ROE: Return on Equity (ROE) decreased to -0.05 on 2023-12-31 from -0.03 on 2022-12-31, representing a change of -101.01%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to -6.65 on 2023-12-31 from -19.93 on 2022-12-31, representing a change of 66.64%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.29 on 2023-12-31 from 0.34 on 2022-12-31, representing a change of -14.95%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Neutral

  Current Ratio: Current Ratio decreased to 2.10 on 2023-12-31 from 2.45 on 2022-12-31, representing a change of -14.23%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Quarterly Financial Ratios

	2024-06-30 Q2	2024-03-31 Q1	Q/Q change %
1486.HK
calendar year	2024	2024	NaN
revenue per share	0.36	0.36	0.00
net income per share	-0.02	-0.02	0.00
operating cash flow per share	0.01	0.01	0.00
free cash flow per share	0.01	0.01	0.00
cash per share	0.3	0.3	0.00
book value per share	1.4	1.4	0.00
tangible book value per share	1.38	1.38	0.00
shareholders equity per share	1.39	1.39	0.00
interest debt per share	0.4	0.32	26.14
market cap	141252599.88	115308244.8	22.50
enterprise value	174673599.88	128847244.8	35.57
pe ratio	-5.79	-4.73	-22.50
price to sales ratio	1.37	1.12	22.50
pocfratio	45.65	37.27	22.50
pfcf ratio	54.88	44.8	22.50
pb ratio	0.35	0.29	22.50
ptb ratio	0.35	0.29	22.50
ev to sales	1.69	1.25	35.57
enterprise value over ebitda	184.64	136.2	35.57
ev to operating cash flow	56.46	41.64	35.57
ev to free cash flow	67.86	50.06	35.57
earnings yield	-0.04	-0.05	18.37
free cash flow yield	0.02	0.02	-18.37
debt to equity	0.28	0.23	21.74
debt to assets	0.18	0.14	21.74
net debt to ebitda	35.33	14.31	146.85
current ratio	2.15	2.15	0.00
interest coverage	-1.28	0	NaN
income quality	-0.51	-0.51	0.00
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.19	0.19	0.00
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0.01	0.01	0.00
capex to operating cash flow	0.17	0.17	0.00
capex to revenue	0.01	0.01	0.00
capex to depreciation	0.04	0.09	-50.00
stock based compensation to revenue	0	0	NaN
graham number	0.81	0.81	0.00
roic	-0.01	-0.01	2.76
return on tangible assets	-0.01	-0.01	0.00
graham net net	0.42	0.42	0.00
working capital	256353000	256353000	0.00
tangible asset value	398250000	398250000	0.00
net current asset value	246687000	246687000	0.00
invested capital	285819000	285819000	0.00
average receivables	356898000	374360500	-4.66
average payables	22998000	26006500	-11.57
average inventory	0	-3502500	100.00
days sales outstanding	311.27	311.27	0.00
days payables outstanding	23.45	23.45	0.00
days of inventory on hand	0	0	NaN
receivables turnover	0.29	0.29	0.00
payables turnover	3.84	3.84	0.00
inventory turnover	0	0	NaN
roe	-0.02	-0.02	0.00
capex per share	0.0	0.0	0.00

• Negative

  ROE: Return on Equity (ROE) decreased to -0.02 on 2024-06-30 Q2 from -0.02 on 2024-03-31 Q1, representing a change of 0.00%. Suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -5.79 on 2024-06-30 Q2 from -4.73 on 2024-03-31 Q1, representing a change of -22.50%. Indicating a decrease in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 2.15 on 2024-06-30 Q2 from 2.15 on 2024-03-31 Q1, representing a change of 0.00%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.28 on 2024-06-30 Q2 from 0.23 on 2024-03-31 Q1, representing a change of 21.74%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 0.12 which is lower than current price 0.35, indicates the company may be overvalued.